← Research library

Bonothyrk: institute clinical report (commercially hosted translation)

Comparison in people · 2011

What was studied
33 women aged 47–56: 20 preparation, 13 controls
Main finding
The 33-person report gives bone mineral density loss categories three months after treatment. The printed category percentages conflict with the stated group sizes.

Reported category of 15–20% bone mineral density loss · At three months, 94.7% in the Bonothyrk group and 90.5% in controls, as printed. The table gives a shared baseline of 90.5%.

Reported findings and study design

33 women aged 47–56 with climacteric symptoms and reduced bone mineral density. Twenty took two 10 mg capsules twice daily (40 mg/day) for 30 days. Thirteen took no intervention aimed at raising bone density. Densitometry was performed before treatment and three months after the course.

Population or model 33 women aged 47–56: 20 preparation, 13 controls

Results · Russian Medical Center report reproduction, methods and densitometry table
MeasureResultComparison, timing and statistics
Reported category of 15–20% bone mineral density lossAt three months, 94.7% in the Bonothyrk group and 90.5% in controls, as printed. The table gives a shared baseline of 90.5%.
Reported category of 20–25% bone mineral density lossAt three months, 5.3% with Bonothyrk and 14.4% in controls, as printed.

The table percentages cannot be reconciled with the stated group sizes and control percentages sum to 104.9%. The category figures do not provide a reliable between-group effect on bone density.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • The signed original has not been authenticated. Allocation and masking are not described. The entry criterion and reported baseline categories are inconsistent. The control percentages do not sum to 100%.
  • The report provides no fracture outcomes or interpretable between-group change in bone mineral density.

Related publications may describe some of the same participants or experiments.

Source details

Institute report — commercial reproduction · PDF

Russian Medical Center report reproduction, methods and densitometry table.

Report reproduction reviewed

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyFull text available

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Bonothyrk: institute clinical report (commercially hosted translation) Institute-attributed report, 2011; commercially hosted brochure pp. 9–10

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards